Literature DB >> 16618448

Characteristics of Castleman's disease in Peru.

Salim Mohanna1, Juvenal Sanchez, Juan Carlos Ferrufino, Francisco Bravo, Eduardo Gotuzzo.   

Abstract

BACKGROUND: Castleman's disease (CD) is a very rare disorder of unknown etiology that is characterized by masses of lymphoid tissue.
METHODS: The records of all patients with a histological diagnosis of CD who were seen at the Hospital Nacional Cayetano Heredia and the Instituto Nacional de Enfermedades Neoplásicas between 1985 and 2003 and 1985 and 2001, respectively, were reviewed.
RESULTS: The study included 10 patients. The age of onset ranged from 5 to 65 years. Nine patients met the criteria for localized CD; six of them were asymptomatic. The most common sites of presentation were the cervical lymph nodes (n=5), submaxilar lymph nodes (n=2), parotid gland (n=1), and lung (n=1). Eight patients had histological evidence of the hyaline-vascular variant and one had the plasma-cell variant. The primary treatment was complete surgical resection. One patient met the criteria for multicentric CD; he was asymptomatic, had histological evidence of the plasma-cell variant, and was treated with combination chemotherapy. All ten patients are currently alive with no evidence of recurrence.
CONCLUSION: The localized form of CD presents as progressive, painless, slow-growing lymph node enlargement that is generally asymptomatic. The locations most commonly involved in the localized form are the cervical lymph nodes, followed by the submaxillary lymph nodes, where it poses a diagnostic challenge to the clinician because it tends to mimic other head and neck diseases. Localized CD is almost always of the hyaline-vascular variant and complete surgical excision of the tumor allows full recovery in all cases.

Entities:  

Year:  2006        PMID: 16618448     DOI: 10.1016/j.ejim.2005.11.012

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  6 in total

1.  Castleman's disease arising from an intrapulmonary lymph node.

Authors:  Toshiteru Tokunaga; Yoshihisa Kadota; Tomoki Utsumi; Masayoshi Inoue; Masato Minami; Meinoshin Okumura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-10-16

2.  Intrapulmonary Castleman's Disease Pretending to Be a Lung Cancer-Work Up of an Intrapulmonary Tumour.

Authors:  Benedikt Haager; Gian Kayser; Severin Schmid; Bernward Passlick; Sebastian Wiesemann
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-11-19       Impact factor: 1.520

3.  Primary mediastinal Castleman's disease.

Authors:  Mohamed A H Regal; Yasser M Aljehani; Hanan Bousbait
Journal:  Rare Tumors       Date:  2010-03-31

4.  International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.

Authors:  Frits van Rhee; Eric Oksenhendler; Gordan Srkalovic; Peter Voorhees; Megan Lim; Angela Dispenzieri; Makoto Ide; Sophia Parente; Stephen Schey; Matthew Streetly; Raymond Wong; David Wu; Ivan Maillard; Joshua Brandstadter; Nikhil Munshi; Wilbur Bowne; Kojo S Elenitoba-Johnson; Alexander Fössa; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Sheila K Pierson; Amy Greenway; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Amy Chadburn; David C Fajgenbaum
Journal:  Blood Adv       Date:  2020-12-08

Review 5.  Recurrence in unicentric castleman's disease postoperatively: a case report and literature review.

Authors:  Na Ren; Lei Ding; Erna Jia; Jinru Xue
Journal:  BMC Surg       Date:  2018-01-04       Impact factor: 2.102

6.  Unicentric Castleman's Disease Arising from an Intrapulmonary Lymph Node.

Authors:  Hideki Ota; Hideki Kawai; Tsubasa Matsuo
Journal:  Case Rep Surg       Date:  2013-06-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.